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Warm sensitive neuronsAlthough studies have shown that chemokines are pyrogenic when injected into the brain, there are no
data indicating which cell types and receptors in the CNS are employed by chemokines such as CCL3 (syn-
onym: MIP-1a) to induce fever in rats. We aimed to study, whether CCL3 induces fever when injected
directly into the thermoregulatory center within the pre-optic area (POA). Moreover, we investigated
whether CCL3 activates cells from POA microcultures resulting in intracellular Ca++ mobilization and syn-
thesis/release of TNF-a and IL-6.
Microinjections of CCL3 into the POA induced a dose-dependent fever, which was accompanied by a
decrease in tail skin temperature. The primary microcultures of the POA (from topographically excised
rat pup brain tissue) were stimulated by bolus administrations of 100 ll CCL3 (0.1 or 0.01 lg) or sterile
PBS as control. We evaluated the responses of 261 (30.89%) neurons, 346 (40.94%) astrocytes and 238
microglia cells (29.17%). Stimulation of rat POA microcultures with CCL3 was capable of inducing Ca++
signaling in 15.31% of all astrocytes and 5.75% of all neurons investigated. No cellular Ca++-signals were
observed after overnight incubation of the cultures with antiCCR1 or antiCCR5 antibodies. CCL3 did not
alter the release of the pyrogenic cytokines IL-6 or TNF-a into the supernatant of the cultures.
In conclusion the present study shows for the ﬁrst time that CCL-3 injected directly into the rat POA,
evoked an integrated febrile response. In parallel this chemokine induces Ca++ signaling in astrocytes
and neurons via both CCR1 and CCR5 receptors when administered to POA microcultures without stim-
ulating the synthesis of TNF-a and IL-6. It is a possibility that CCL3-induced fever may occur via CCR1 and
CCR5 receptors stimulation of astrocytes and neurons from POA.
 2013 Elsevier Inc. All rights reserved.1. Introduction
The rostral hypothalamus, especially the pre-optic area of the
anterior hypothalamus (POA), contains temperature-sensitive and
-insensitive neurons that form synaptic networks to control ther-
moregulatory responses (Dinarello et al., 1988; Boulant, 2000).
Although it is well established that the febrile response is triggered
and regulated on the level of the POA, it is not clear how the medi-
ators peripherally synthesized reach the brain tissue and alter the
properties of the thermoregulatory center (Blatteis, 2006; Roth
et al., 2009).The substances which can act on POA for evoking a febrile re-
sponse are named pyrogens. Those can be divided in two catego-
ries: exogenous and endogenous. In general, most of exogenous
pyrogens are components from bacteria, virus, fungi and parasites
The endogenous pyrogens are thermo-labile proteins and lipid
mediators and are produced/released by the stimulation with
exogenous pyrogens or trauma, lesions or stress (for review see
Zeisberger, 1999; Blatteis, 2006).
Endogenous pyrogens include a number of the cytokines, corti-
cotrophin releasing factor, endothelins and chemokines (Fabricio
et al., 2005; Soares et al., 2008; Machado et al., 2007, for review
see Roth et al. (2006)). Chemokines are a family of structurally re-
lated proteins (8–15 kDa) that play a pivotal role in inﬂammation,
sharing the ability to induce migration and activation of speciﬁc
subsets of leukocytes (Baggiolini et al., 1994; Pease and Williams,
2006).
A role of the chemokines on the manifestation of a febrile re-
sponse was ﬁrst evidenced by the capacity of MIP-1 to induce fever
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have contributed to the comprehension of the role of different che-
mokines on fever induction and maintenance (Zampronio et al.,
1994; Soares et al., 2006; Machado et al., 2007; Soares et al.,
2008, 2009).
We previously demonstrated that i.c.v. injection of CCL3 in-
duces an integrated febrile response evidenced by the increase in
core body temperature coinciding with tail skin vasoconstriction
(Soares et al., 2006). Nonetheless, there are no published data
showing which cells of the CNS, namely within the POA, are di-
rectly responsive to CCL3 and thereby involved in the pyrogenic ef-
fects of this chemokine.
Recent studies have shown that chemokines and their receptors
are located throughout the brain, but are not uniformly distributed.
Among chemokines and their receptors that are arrayed dispropor-
tionately in glia and neurons are monocyte chemotactic protein-1/
(CCL2), fractalkine/(CX3CL1), interferon-gamma-inducible-pro-
tein-10/(CXCL10), RANTES/(CCL5) and CCL3. In the brain, they are
found in the hypothalamus, nucleus accumbens, limbic system,
hippocampus, thalamus, cortex, and cerebellum. The uneven dis-
tribution suggests that there may be functional roles for the che-
mokine ‘‘system,’’ comprised of chemokine ligands and their
receptors (Adler and Rogers, 2005; Adler et al., 2006).
It is known that CCL3 binds on CCR1 and CCR5 which are ex-
pressed on neurons, microglia and astrocytes within the CNS
(Galasso et al., 1998; Bajetto et al., 1999; Eltayeb et al., 2007; Kner-
lich-Lukoschus et al., 2011). Therefore it seems possible that CCL3,
by binding on these receptors, activates POA cells and induces fe-
ver by either directly evoking thermo-effector responses via path-
ways descending from the POA or by stimulating the synthesis/
release of other endogenous pyrogens as secondary mediators,
such as PGE2 (Nakamura, 2011).
We thus aimed to investigate whether CCL3, when injected into
the pre-optic area, induces an integrated febrile response. More-
over, we investigated if the chemokine CCL3 directly activates
CCR1 and CCR5 cells from POA microcultures (neurons, microglia
or astrocytes) resulting in Ca++ mobilization and synthesis/release
of putative endogenous pyrogens (TNF-a and IL-6).2. Experimental procedure
2.1. Animals
The in vivo experiments were conducted on male Wistar rats
weighing 180–200 g, housed individually at 24 ± 1 C under a
12:12 h light-dark cycle (lights on at 06:00 AM) with free access
to food and tap water until the night before the experiment, when
only water was made available. Each animal was used only once.
Care and use of the animals were in full compliance with the Eth-
ical Principles in Animal Research adopted by the Brazilian College
of Animal Experimentation (COBEA) and Guide for the Care and
Use of Laboratory Animals of the Institute for Laboratory Animal
Research (National Research Council, 1996), and the study was pre-
viously approved by the Animal Research Ethics Committee of the
Faculty of Medicine Ribeirão Preto Campus, University of São Paulo
(protocol number 08.1.1404.53.8).
Wistar rat pups of both sexes obtained from an in-house breed-
ing colony were used for all in vitro experiments, with parent ani-
mals originating from Charles River WIGA (Sulzfeld, Germany).
Animal care, breeding and experimental procedures have been
conducted according to the guidelines approved by the Hessian
Ethical Committee. Adult rats had free access to drinking water
and standard lab chow; the pups were reared by their mothers in
large M4-size cages. Room temperature was controlled at24 ± 1 C and relative humidity at 50 percent, and artiﬁcial lights
were on from 7:00 AM to 7:00 PM.
2.2. Implantation of the intrahypothalamic cannula
The rats were anaesthetized with a mixture of ketamine and
xylazine (58 mg kg1 and 20 mg kg1, respectively, intraperitoneal
(i.p.) and stereotaxically, unilaterally implanted with a permanent
24-gauge stainless steel guide cannula (0.55 mm outer diameter,
15 mm long) into the AH/POA. The stereotaxic coordinates were:
0.6 mm lateral to the midline, 7.7 mm anterior to the interaural
line, and 6.5 mm under the brain surface; and the incisor bar was
lowered 3.0 mm below the horizontal zero, according to Paxinos
and Watson (1997). Cannulae were ﬁxed to the skull with jewel-
ler’s screws embedded in dental acrylic cement. All procedures
were conducted under aseptic conditions. Animals were treated
with oxytetracycline hydrochloride (400 mg kg1, i.m.) and al-
lowed to recover for 1 week prior to experimental use.
2.3. Intra-POA CCL3 injection and rectal or skin measurements
temperature measurement
In the ﬁrst series of experiments we aimed to determine the
dose of CCL3, which was able to induce a febrile response in rats.
For this purpose, CCL3 at doses of 1, 5, 25 and 50 pg or sterile saline
was microinjected into the AH/POA, and the animals’ rectal tem-
perature was monitored by telethermometry for up to 6 h. More-
over, in order to verify the effect of intra AH/POA injection of
CCL3 on the heat loss index (Romanovsky et al., 2002), 25 pg of
the chemokine was administered into that area and the rectal
and tail skin temperatures were measured by telethermometry
using a thermistor probe attached with adhesive tape to the lateral
surface of the proximal segment of the tail (Figueiredo et al., 2010).
The aseptically performed microinjections into the AH/POA
took place between 10:00 and 11:00. For this purpose, a 30-gauge
needle, connected to polyethylene (PE10) tubing, was used. The
needle protruded 2 mm beyond the cannula tip and a 500 nl vol-
ume was injected slowly (over 1 min) with a 25 ll Hamilton syr-
inge coupled to a microinfusion pump (KD Scientiﬁc, model
KDS101, EUA). After injection, the needle remained in place for
30 s before it was withdrawn to prevent backﬂow of the injection
ﬂuid through the cannula.
The rectal temperature was measured in conscious and unre-
strained rats for 1 min every 30 min for up to 6 h, by gently insert-
ing, 4 cm into the rectum, a vaseline-coated thermistor probe
(model 402 coupled to a model 46 telethermometer, Yellow
Springs Instruments, Ohio, USA.), without removing the animals
from their home cages.
Experimental measurements were conducted at the thermo-
neutral zone for rats (Gordon, 1990), in a temperature-controlled
room kept at 28 ± 1 C, following adaptation of the animals to this
environment for at least 1 h. After this period, baseline tempera-
tures were determined 4 times at 30 min intervals prior to any
injection; only animals displaying mean basal rectal temperatures
between 36.8 C and 37.2 C were selected. To minimize core tem-
perature changes due to handling, animals were conditioned twice
to this environment and procedure on the preceding day.
2.4. Histology
Each rat was microinjected into the POA (300 nl) with Evan’s
Blue (2.5%). Immediately after the dye microinjection, each rat
was given a lethal dose of pentobarbital, perfused transcardially
with 0.9% saline, followed by 4% paraformaldehyde. Each brain
was removed, stored in the same ﬁxative for 6 h, kept in 30% su-
crose overnight, and cut at 40 lm on freezing microtome. From
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position of the cannulae and the respective perfusion sites were
subsequently veriﬁed and ‘‘mapped’’ anatomically. Animals show-
ing cannula misplacement or blockage upon injection, or abnormal
weight gain patterns during the post-implantation period were ex-
cluded from the study.2.5. Isolation and cultivation of POA primary cell cultures
Primary microcultures of the rat POA were established from
topographically excised brain tissue of ﬁve to six day old Wistar
rat pups. The animals were decapitated, the brains removed from
the skull under aseptic conditions and transferred to 3 cm Petri
dishes ﬁlled with cold, oxygenated GBSS (Gey’s Balanced Salt
Solution; Biotrend, Köln, Germany) containing 5% D-glucose (Sigma
Aldrich, Munich, Germany). A thin slice (400 lm) containing the
anterior commissure was cut with a vibratome, and the POA
including tissue (Fig. 1) was dissected from the slice using ﬁne
eye scissors.
The isolated POA tissue was transferred into Petri dishes con-
taining oxygenated HBSS (Hanks Balanced Salt Solution without
Ca2+ and Mg2+; Biochrom, Berlin, Germany) supplemented with
20 mM HEPES (Sigma Aldrich) pH 7.4. The supernatant was re-
moved, and POA fragments were treated with 2 ml dispase (1 U/
ml; Roche Diagnostics, Mannheim, Germany) in oxygenated HBSS
with 20 mM HEPES, pH 7.4, for 30 min at 37 C. After incubation
the tissue was washed with 1 mM EDTA (Sigma Aldrich) in HBSS
to inactivate the enzyme. After three washes with 3 ml complete
medium consisting of Neurobasal medium A supplemented with
2% B 27 (Invitrogen, Karlsruhe, Germany), penicillin (100 U/ml)/
streptomycin (0.1 mg/ml) and 2 mM L-glutamine (Biochrom),
2 ml complete medium were added to each tube and the tissue
was dissociated by repeated trituration with a 1 ml eppendorf pip-
ette. The dissociated POA cells were plated onto pre-warmed, poly-
L-lysine (1 mg/ml H2O; Sigma Aldrich) coated CELLocate glass
coverslips (Eppendorf, Hamburg, Germany) forming the bottom
of a reusable Flexiperm-micro-12 well (6 mm diameter; Greiner
Bio-One GmbH, Solingen, Germany) to ensure sufﬁcient cell den-
sity despite limited absolute cell number, and cultured in a humid-
iﬁed atmosphere of 5% CO2 and 95% air at 37 C. The medium was
exchanged the next day to remove cellular debris and thereafter
every two days during the culture period. The cells were employedFig. 1. Illustration of tissue prepared for primary microcultures of the rat POA.
Schematic illustration of tissue prepared for primary microculture of the rat POA.
From each rat pup brain, a coronal brain slice (600 lm; bregma 0.00 mm to bregma
0.60 mm) was cut with a microtome. The borders at the front and at the back of the
prepared tissue slice are indicated by line drawings modiﬁed from Paxinos and
Watson (2005). The square indicates the POA tissue, which was dissected from the
slice using ﬁne eye scissors under microscopic control (ac = anterior commissure,
cc = corpus cullosum, oc = optic chiasm, LV = lateral ventricle, 3 V = third ventricle).for intracellular calcium measurements and a subsequent
immunocytochemical characterization; supernatants were used
for determination of cytokines.
2.6. Substances used for stimulation of POA primary cell cultures
CCL3/MIP-1a (>97% Purity, recombinant mouse, Catalog Num-
ber 450-MA/CF, Lot CA1209042) was purchased from R&D Systems
(Minneapolis, MN, USA). CCL3 was dissolved in phosphate buffered
saline (PBS, pH 7.4) at concentrations of 1 lg/ml or 1 ng/ml and
added to the perfusion chamber by bolus application of 0.1 or
0.01 lg/100 ll, respectively, during a 1 min arrest of the superfu-
sion pump (minipuls-3; Abimed Analysen-Technik, Langenfeld,
Germany). The dose was chosen according to preliminary record-
ings from pilot studies, in which several doses were tested. A bolus
control application with PBS was performed prior to stimulation
with CCL3.
For the CCR1 and CCR5 blocking test, both anti-CCR5 (Monoclo-
nal Anti-human CCR5 Antibody, Catalog number MAB181 Lot
AJB11) and anti-CCR1 (Anti-mouse CCR1 Antibody, Catalog
number AF5986 Lot CDQE01) were purchased from R&D Systems
(Minneapolis, MN, USA). Antibodies were dissolved in phosphate
buffered saline (PBS, pH 7.4) at concentrations of 25 lg/ml. The
incubation with either anti-CCR1 or anti-CCR5 antibodies (2.5ug/
100 ll) was performed either 1 h or overnight before the stimula-
tion with CCL3.
At the end the experiment, cells were exposed to ‘‘high potas-
sium buffer’’ (1.5 mM HEPES (Roche Diagnostics), 43 mM NaCl,
50 mM KCl, 1.5 mM MgCl2, 1 mM CaCl2 (all from Merck, Darms-
tadt, Germany) and 10 mM D-glucose (Sigma Aldrich). This treat-
ment served as vitality test, especially for neurons.
2.7. Fura-2 ratio imaging technique to measure intracellular Ca2+-
levels after CCL3 cellular activation
After 5–6 days cultivation on individual CELLocate glass cover-
slips, the cells were loaded with 2 lM fura-2-AM (MoBiTec GmbH,
Göttingen, Germany) in complete medium for 45 min in a
zhumidiﬁed atmosphere of 5% CO2/95% air at 37 C. For intracellu-
lar Ca2+-measurements, the coverslips were placed under an in-
verted microscope (IMT-2; Olympus Optical, Hamburg, Germany)
in a specially constructed Teﬂon culture chamber (Max-Planck
Institute, Bad Nauheim, Germany) and superfused with buffer con-
sisting of 5 mM HEPES (Roche Diagnostics), 130 mM NaCl, 5 mM
KCl, 1 mM MgCl2, 1.25 mM CaCl2 (Merck, Darmstadt, Germany)
and 10 mM D-glucose (Sigma Aldrich). Fluorescence measurements
were performed using a ﬁlterwheel-based excitation system and
analyzed with MetaFluor 4.5 software (Visitron, Puchheim, Ger-
many). After deﬁning regions of interest for single neurons, astro-
cytes or microglial cells by a continuously variable aperture, the
time course of emitted ﬂuorescence (>515 nm) after alternating
excitations at 340 and 380 nm, respectively, was recorded at
0.2 Hz using a Visicam 12 BIT digital CCD-camera (Visitron). The
340/380 ratios proportional to [Ca2+]i were computed and data
were transferred to Excel (Windows Microsoft, Munich, Germany)
for further analysis.
2.8. Immunocytochemical characterization of cellular phenotypes
After the imaging experiments, the phenotypic identiﬁcation of
cultured neurons and glial cells was conﬁrmed by immuno-label-
ing with polyclonal antisera or monoclonal antibodies directed
against cell-speciﬁc marker proteins such as glial ﬁbrillary acidic
protein for astrocytes (rabbit anti GFAP; DAKO, Glostrup, Den-
mark), MAP2a + b for neurons (mouse AP-20 anti MAP2a + b; Sigma
Aldrich), ED-1 for microglial cells (mouse anti rat-ED-1; AbD Sero-
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anti-CNP; Sigma Aldrich), Fibronectin for endothelial cells (poly-
clonal rabbit anti-human, A0245, Dako, Hamburg, Germany) and
von Willebrand Factor for ﬁbroblasts (polyclonal rabbit anti-hu-
man, A0082, Dako, Hamburg, Germany) (Fig. 4). Therefore, subse-
quent to Ca2+ measurements, the cells were ﬁxed with 4% freshly
prepared paraformaldehyde (Merck, Darmstadt, Germany) in
0.1 M phosphate buffer (PB), pH 7.4, for 15 min at RT. The cells
were cultured and attached on the individual CELLocate glass cov-
erslips, which possess grids oriented by numbers and letters. Using
these precise coordinates, it was possible determine the position of
the studied cells and determine the phenotype of cells responding
with measurable Ca2+ signals, observed in the imaging procedure.
The ﬁxed cells were rinsed three times in PBS, followed by a
60 min incubation in blocking buffer containing 10% FCS (PAA,
Pasching, Austria) diluted in PBS containing 0.05% Triton X-100
(PBS-Triton) (Sigma Aldrich). The incubation with the primary
antibodies (anti-GFAP 1:800, anti-MAP2a + 2b 1:600, anti-ED1
1:2000, anti-CNPase 1:300) diluted in blocking buffer was carried
out for 48 h at 4 C in a humidiﬁed chamber. Unbound antibodies
were removed by three washes for 5 min each in PBS-Triton.
Thereafter cells were incubated with secondary antisera such as
Alexa-350-donkey anti-mouse IgG (H + L), Alexa-488-donkey
anti-rabbit IgG (H + L) or anti-mouse IgG (H + L) (MoBiTec GmbH)
or Cy3-goat anti-mouse IgG (H + L) (Dianova, Hamburg, Germany)
at a 1:500 or 1:800 dilution in blocking buffer for 2 h at RT. After
three 5 min washes in PBS-Triton, the coverslips were embedded
using a glycerol/PBS solution (Citiﬂuor LTD, London, UK). 2,3-
Diamidin-20-Phenylindol-dihydrochlorid (DAPI; Mobitec GmbH)
was used for ﬂuorescence staining of all cell nuclei. With an Olym-
pus BX50 epiﬂuorescent microscope (Olympus Optical), the cells
were found according to CELLocate glass coverslips coordinates,
examined and photographed with the appropriate ﬁlter sets.
2.9. Measurements of TNF-a and IL-6 in supernatants of POA
microcultures
After 5–6 days cultivation on CELLocate glass coverslips, the
POA cells were incubated with CCL3 (100 ng/ml) in complete med-
ium for 60, or 120 min in a humidiﬁed atmosphere of 5% CO2/95%
air at 37 C. After selected time intervals of incubation, the super-
natants were removed from the cells, transferred and stored at
45 C for later determination of cytokines. As positive controls
some samples were incubated with lipopolysaccharide (LPS, Sig-
ma–Aldrich; 10 lg/ml).
Determination of TNF-a was performed by a bioassay based on
the cytotoxic effect of TNF-a on the mouse ﬁbrosarcoma cell line
WEHI 164 subclone 13 (Espevic and Nissen-Meyer, 1986). The as-
say was performed in sterile, 96-well microtitre plates. Serial dilu-
tions of biological samples or different concentrations of a murine
TNF-a standard (code 88/532; National Institute for Biological
Standards and Control, South Mimms, UK) were incubated for
24 h in wells, which had been seeded with 50,000 actinomycin
D-treated WEHI cells. The number of surviving cells after 24 h
was measured by use of the dimethylthiazol-diphenyl tetrazolium
bromide (MTT) colorimetric assay (Holt et al., 1991). Microculture
supernatants were pre-diluted so that serial dilution of samples
and standard dilution curves were parallel. The detection limit of
the assay, after considering the dilution of samples for the assays,
proved to be 6 pg/ml TNF-a. Determination of IL-6 was performed
by a bioassay based on a dose-dependent growth stimulation of IL-
6 on the B9 hybridoma cell line (Aarden et al., 1987). The assay was
performed in sterile, 96-well microtitre plates. In each well, 5000
B9 cells were incubated for 72 h with serial dilutions of biological
samples or with different concentrations of human IL-6 standard
(code 89/548; National Institute of Standards and Control, SouthMimms, UK). According to NIBSC 1 lg of this IL-6 standard
corresponds to 100,000 international units (I.U.). The number of
living cells in each well was measured by use of the MTT assay
(see above). The detection limits of the assay, after considering
the dilution of samples for the assays, proved to be 3 international
units (IU) IL-6/ml.
The levels TNF-a and IL-6, which we determined in our samples,
do not reﬂect absolute cytokine concentrations but rather bioactiv-
ity in relation to established international standards. To conﬁrm
the speciﬁcity of the assays, we added 1 lg of a neutralizing TNF
binding protein (TNFbp), a synthetic form of the type1 soluble
TNF-receptor (Ross et al. 2003) or 10 ll of a neutralizing antiserum
against rat-IL-6 (Harden et al. 2011) to the supernatants of some
stimulated microcultures. The presence of TNFbp or IL-6-antise-
rum abrogated TNF- or IL-6-bioactivity in these samples com-
pletely (TNF) or almost completely (IL-6). A commercial rat IL-1b
ELISA assay (900-K91; Prepro Tech, Hamburg, Germany) was em-
ployed to determine the putative release of IL-1b into the superna-
tants of CCL3- or LPS-stimulated POAmicrocultures. The sensitivity
of this assay was not sufﬁcient to detect quantiﬁable amounts of
immunoreactive IL-1b in these samples.
2.10. Data evaluation and statistics
For data analysis, the baseline temperature prior to any injec-
tion was determined for each animal and all variations in body rec-
tal or tail skin temperature were expressed as changes from the
mean basal value (i.e., as DT, in C). The heat loss index (HLI)
was used to evaluate thermoeffector responses of the tail skin vas-
culature. The HLI was calculated according to the formula:
HLI ¼ Tsk Tað Þ Tc Tað Þ1
Tsk = tail skin temperature; Ta = ambient temperature and
Tc = body temperature. The values of HLI will vary from 0 to 1.0,
representing states of maximum vasoconstriction to maximum
vasodilation, respectively (Romanovsky et al., 2002). Results are
presented as mean ± standard error of the mean (SEM), and mean
baseline temperatures were not statistically different among the
groups. DT and HLI responses were compared across treatments
and time points analyzed by two-way ANOVA for repeated mea-
sures followed by the Bonferroni test. All data were analyzed using
the Prism computer software (Graph-Pad, San Diego, CA, USA).
The numbers of CCL3 responsive cells of a given cellular pheno-
type under determined experimental conditions were expressed as
percentage (%) of all cells of this phenotype investigated. Stimulus-
induced transient increases of [Ca2+]i were expressed as the differ-
ence between resting [Ca2+]i measured prior to the respective stim-
ulation and the stimulus-induced [Ca2+]i peak (Dratio [340/
380 nm]). A difference in Dratio [340/380 nm] of more than 0.1
was considered to be a stimulus-induced Ca2+ signal, which can
be regarded as a strict exclusion criterion, and Dratio values are
presented as means ± standard error of the mean (SEM).
Levels of bioactive TNF-a and IL-6 were also shown as mean-
s ± SEM and compared by an analysis of variance (ANOVA) fol-
lowed by Scheffe’s post-hoc test. Because the values for cytokines
are not normally distributed, a log transformation of the individual
cytokine values was performed prior to the statistical calculation.
The calculations were carried out using the software package Stat-
View (Abacus Concepts, Berkeley, CA, USA).3. Results
In our experimental conditions sterile saline (SAL; 500 nl) in-
jected into AH/POA did not alter the rectal and tail skin tempera-
ture or HLI above or below baseline values for up to 6 h (Fig. 2A).
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and C) of 5, 25 or 50 pg/500 nl of CCL3 caused a dose-dependent in-
crease of the animals’ body temperature while 1 pg of CCL3 did not
change the basal temperature of the rats. Five pg of CCL3 increased
body temperature with a peak at 0.5 h (P < 0.05 Fig. 2A); 25 and
50 pg of CCL3 promoted a substantial and similar increase in body
temperature, peaking 2 h after its administration (P < 0.001;
Fig. 2A) and remaining elevated until the end of the investigation
period (6 h).
Because doses of 25 or 50 pg of CCL3 were equally active in
increasing the rats’ temperature, the lower one was chosen for
the next experiment.
The increase in rectal temperature produced by the injection of
25 pg of CCL3 into the AH/POA (P < 0.01; Fig. 3A) was accompanied
by a signiﬁcant reduction in the tail skin temperature (P < 0.01;
Fig. 3B). This result indicates a local (tail-skin) vasoconstriction,
what can also be shown by the reduction in heat loss index (HLI)
values (P < 0.01; Fig. 3C).0 1 2 3 4 5 6
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C3.1. CCL3 induces calcium signaling in astrocytes and neurons of POA
micro-cultures
Primary rat POA microcultures after 5–6 days of in vitro differ-
entiation contained small-sized bi- or tripolar neurons expressing
microtubule-associated protein 2a + b, squamous or stellate
astrocytes richly endowed with cytoskeletal GFAP, mature oligo-
dendrocytes expressing CNPase and microglial cells staining for
ED-1 (c.f. Fig. 4). Endothelial cells and ﬁbroblasts proved not to
be present as indicated by negative immunolabeling for ﬁbronectinA
B
Fig. 2. Increase in rectal temperature induced by intrahypothalamic injection of
CCL3. CCL3 at indicated doses or sterile saline was microinjected into AH/POA (A).
The rectal temperature was evaluated by telethermometry. Values represent the
means ± SEM of variation in rectal temperature (DT, C) observed in ﬁve animals in
each group. Basal temperatures (mean ± SEM; C) for the different groups: s,
37.1 ± 0.05, N, 37.1 ± 0.06; j, 37 ± 0.08; d, 37 ± 0.07; , 37 ± 0.06; ⁄⁄P < 0.01 when
compared to control saline in panel A. Representative photomicrograph (right
panel) and schematic representation (left panel) of coronal section illustrating the
site of microinjection into the POA (B). Abbreviations: 3v, third ventricle; Lv, lateral
ventricle; och, optic chiasm; so, supraoptic nucleus.
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Fig. 3. Effect of intrahypothalamic injection of CCL3 on core and tail skin
temperature of the rat. CCL3 (25 pg) or sterile saline was microinjected into AH/
POA in a volume of 500 nl. Values shown represent means ± SEM of the variation in
degree Celsius of rectal temperature (DTr) (A), tail skin temperature (DTtail) (B) and
the heat loss index (HLI) (C) observed in 6 animals of each group. Rectal and tail skin
temperatures were evaluated by telethermometry. Basal temperatures (mean ± -
SEM, C) were as follows: panel A: s, 36.8 ± 0.18; d, 36.9 ± 0.37; panel B: h,
32.8 ± 0.16; j, 32.9 ± 0.04. ⁄P < 0.05 when compared to the saline treated control
group.and Von Willebrand factor (data not shown). Cells of all four phe-
notypes were subjected to intracellular calcium imaging after CCL3
treatment.
Examples of Fura-2-loaded POA astrocytes or neurons respond-
ing to a bolus application of CCL3 with a sharp and transient in-
crease of [Ca2+]i is shown in Fig. 5. The CCL3-induced Ca2+ -signal
occurred within seconds after CCL3 administration, while bolus
injections of an equivalent volume of buffer had no effect on
[Ca2+]i, thus excluding non-speciﬁc mechanic stimulation of the
investigated cell. 0.001, 0.01 or 0.1 lg/100 ll of CCL3 were applied
in the microcultures of POA. Either 0.01 or 0.1 produced similar ef-
fects in elevating the intracellular calcium concentration [Ca2+]i. A
dose of 0.001 lg/100 ll did not affect the [Ca2+]i. Therefore a dose
of 0.01 lg has been chosen for proceeding with the Ca2+ mobiliza-
tion experiments.
Fig. 6 summarizes the responses of all POA cells investigated.
The data presented on top of Fig. 6 came from the analysis of about
261 neurons, 346 astrocytes, and 238 microglial cells, derived from
Fig. 4. Cellular phenotypes in primary microculture of the rat POA. Phenotypic characterization of the cell types in the primary microculture of POA cells by immunolabeling
with primary antisera/antibodies directed against cell-speciﬁc marker proteins [MAP2a + b for neurons (A), GFAP for astrocytes (B), CNPase for oligodendrocytes (C) and ED-1
for microglial cells (D)]. Secondary antisera employed were coupled to ﬂuorophors such as Alexa-488 (A), Alexa-350 (D) or Cy3 (B, C). Bar represents 20 lm.
Fig. 5. Examples for CCL3-induced Ca2+-signaling in cells of a primary POA
microculture. Examples of typical Ca2+-tracings illustrating the responsiveness of
a neuron, an astrocyte and a microglia cell from POA to a bolus application of CCL3.
The ratio [340/380 nm] ﬂuorescence intensity is proportional to [Ca2+]i. CCL3 was
administered to the microchamber by bolus application reaching a ﬁnal concen-
tration of 100 or 10 ng/ml. Bolus application of buffer without CCL3 had no effect on
[Ca2+]i. Buffer containing a high concentration (50 mM) of KCl served as vitality test,
especially for neurons and to some degree for astrocytes.
D.M. Soares et al. / Brain, Behavior, and Immunity 34 (2013) 120–129 12542 different POA culture wells. Of all these cells, 44 astrocytes, 15
neurons, but no microglial cells responded to CCL3-stimulation
with a pronounced elevation of [Ca2+]i. These numbers corre-
sponded to 5.75% of neurons, 15.31% of astrocytes and 0% of
microglial cells investigated (Fig. 6A). It is worthwhile to mention
that neurons responding to CCL3 stimulation were located in close
vicinity to astrocytes. The mean strength of the CCL3-induced Ca2+
-signals was similar in the phenotypes of cells investigated, withaverage ratio [340/380 nm] values of about 0.11 and 0.17 for neu-
rons and astrocytes, respectively (Fig. 6B).
3.2. Incubation with either anti-CCR1 or anti-CCR5 antibodies blocks
the CCL3-induced calcium signaling cells from POA micro-cultures
In order to investigate the effect of CCR1 or CCR5 blockade we
performed two experiments, in which we employed antibodies
against the respective receptors. In the ﬁrst experiment we admin-
istered the antibody 1 h before the stimulation with CCL3. Never-
theless, when the POA cell culture was stimulated with a bolus
injection of CCL3, calcium signals were observed even with the
anti-CCR1 or anti-CCR5. We hypothesized that the duration of
the pre-incubation period was not sufﬁcient to cause the total
blocking of the receptors. Therefore we performed an overnight
incubation with either anti-CCR1 or anti-CCR5 on the cultures be-
fore the stimulation with CCL3 to assure that the antibody would
have enough time to promote an effective binding to the receptor.
Indeed, when we performed the stimulation with CCL3 after the
overnight pre-incubation with anti-CCR1 we did not observe any
response from 60 neurons, 74 astrocytes and 1 microglial cell
(Fig. 7). Similarly, we did not observe any signal from 77 neurons
and 128 astrocytes, when the overnight pre-incubation with
anti-CCR5 was realized before the stimulation with CCL3.
3.3. CCL3 does not induce formation of TNF and IL-6 by cells of POA
micro-cultures
Due to the fact that a substantial number of POA astrocytes
were directly responsive to CCL3-stimulation, we decided to
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Fig. 6. CCL3-induced Ca2+-signaling in a primary POA microculture system. (A):
Numbers and percentages of POA cells responding to CCL3 (bolus application of
100 ng/ml) with an elevation intracellular Ca2+-concentration [Ca2+]i. N = number of
cells tested; seven neurons and 44 astrocytes were responsive to CCL3. (B): Dratio
[340/380 nm] ﬂuorescence values as measure of [Ca2+]i. Columns represent
means ± SEM of the responsive cells for each cell type.
Fig. 7. Examples for CCL3-induced Ca2+-signaling in cells of primary POA micro-
cultures pre-incubated with anti-CCR1 antibody. Responsiveness of POA-cultured
neurons, astrocytes and a microglia to bolus application of CCL3 after a 24 h pre-
incubation with anti-CCR1 antibody (2.5 lg). The ratio [340/380 nm] ﬂuorescence
intensity is proportional to [Ca2+]i. CCL3 was administered to the microchamber by
bolus application reaching a ﬁnal concentration of 100 ng/ml. Bolus application of
buffer without CCL3 had no effect on [Ca2+]i. Buffer containing glutamate (105 M)
served as a positive control to answer of the cells. High concentration (50 mM) of
KCl served as vitality test, especially for neurons and to some degree for astrocytes.
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Fig. 8. TNF-a and IL-6 concentrations in supernatants of CCL3-stimulated POA
microcultures. The supernatants of POA microcultures were collected 60, or
120 min after stimulation with pure medium (control), CCL3 (ﬁnal concentration:
100 ng/ml) or LPS (10 lg/ml), and concentrations of TNF-a (A) and IL-6 (B) were
determined by speciﬁc bioassays. Columns represent means with SEM (n = 3–5).
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those cytokines (TNF-a, IL-6) that are implicated in the manifesta-
tion of brain-controlled illness responses. In a ﬁrst experiment the
concentrations of bioactive cytokines (TNF-a, IL-6) were deter-
mined in supernatants of cultured POA cells incubated with CCL3
or buffer for 60 and 120 min. The results of these measurements
are summarized in the Fig. 8.
Neither 60 nor 120 min after the start of incubation with CCL3
(0.01 or 0.1 lg/ml) concentrations of bioactive TNF-a or IL-6 weresigniﬁcantly elevated in the supernatants of POA microcultures
compared to those stimulated with vehicle (Fig. 8A and B, respec-
tively). As a positive control some samples were stimulated with
LPS instead of CCL3. Incubation of POA microcultures with LPS
caused a signiﬁcant increase of TNF-a at 60 min and 120 min
(Fig. 8A). Similarly, we observed a signiﬁcant rise of bioactive IL-
6 in the supernatant of LPS-stimulated POA-cultures at 60 min
and 120 min (Fig. 8B). These data indicate that the fever promoting
effect of CCL3 is not mediated via a stimulated formation of TNF-a
or IL-6 within the POA.4. Discussion
We demonstrated that CCL3 not only induces an integrated feb-
rile response when injected into the POA, but also is capable of
inducing calcium signals in a population of astrocytes and neurons
via CCR1 and CCR5 receptors, when administered as a bolus to neu-
ro-glial microcultures of the rat preoptic area without changing the
levels of the cytokines TNF-a and IL-6 in the supernatants of the
CCL3-stimulated cells.
Some authors have shown that CCL3 is capable of increasing the
rectal temperature of rats when injected into the hypothalamus or
into the anterior hypothalamic preoptic area (POA) (Myers et al.,
1993; Miñano et al., 1996). Nonetheless, it remained to be deter-
mined whether the pyretic action of CCL3 would constitute an
integrated fever response, which is accompanied by appropriate
thermoeffector responses. The current study resolves this issue
by demonstrating that the increase in core body temperature in-
duced by CCL3 injected into the POA was accompanied by signiﬁ-
cant reduction of the heat loss index (HLI; Romanovsky et al.,
2002). The reduction of HLI was reﬂected by a signiﬁcant decrease
of tail skin temperature, indicating vasoconstriction of the local
(tail) vascular bed aimed to retain heat, which is a characteristic
feature of the febrile response (O’Leary et al., 1985). The rat’s tail
serves as a variable heat exchanger (O’Leary et al., 1985; Gordon,
D.M. Soares et al. / Brain, Behavior, and Immunity 34 (2013) 120–129 1272002), since its blood ﬂow is regulated by the activity of sympa-
thetic vasoconstrictor nerves, speciﬁcally controlled by neurons
of the raphé magnus/pallidus nuclei (Blessing and Nalivaiko,
2001). Thus, it seems that CCL3, injected into the POA, evokes a
concerted thermoregulatory response by stimulating vasoconstric-
tion of cutaneous vessels via an efferent thermoregulatory path-
way, in which the reduced efﬁcacy of the tail skin to dissipate
body heat collaborates with the progress of fever.
Astrocytes represent the main cellular phenotype, which was
responsive to CCL3 in the POA cell culture. It is worthwhile to note
that just about 15% of all investigated astrocytes responded to
CCL3, suggesting that only a subpopulation of astrocytes presents
speciﬁc receptors for the CCL3 coupling. Interestingly, there is a
current debate about the essential characteristics of an astrocyte.
For example, the ependymoglia often exhibit some astrocyte-like
features (Kettenmann and Ransom, 1988) but are not habitually
considered as astrocytes. Conversely, the convergence of anatomi-
cal phenotype between radial glia and the elongated radially ori-
ented astrocytes present in areas such as the supraoptic nucleus
(Bonfanti et al., 1993) and their capacity to differentiate into astro-
cytes, have contributed to suggestions that radial glia be classiﬁed
more broadly as astrocytes (Kimelberg, 2010). It is probable that
future classiﬁcations of astrocytes will recognize many cells with
a continuum of functions, phenotypes and cellular origins under
the broad descriptor ‘‘astrocyte’’ rather than placing an emphasis
on a few discrete categories.
We also observed a small population of neurons in the POA cell
culture, which directly responded to CCL3 stimulation increasing
intracellular calcium. In view of that, we can hypothesize a direct
activation of neurons, which might belong to thermoregulatory
relevant structures within the POA or, at least project to those,
and thus contribute to the generation of fever and other brain-con-
trolled signs of illness (Romanovsky et al., 2009, Dantzer, 2009).
Nonetheless, it is essential to mention that some neurons were
placed close to one or more astrocytes. A good cell selection for
the intracellular Ca2+ measurements is based on cellular differenti-
ation, cell types present in the microscopic ﬁeld and spacing be-
tween cells. It is important to avoid cells with microscopically
visible intercellular contact zones. Nevertheless, sometimes the
cells are still very close to each other. Neurons generally need
astrocytic feeder cells in their vicinity, and astrocytes tend to clus-
ter (Ott et al., 2010, 2012). Therefore, we cannot exclude the possi-
bility that a part or even all of the CCL3-responsive neurons might
have been indirectly activated by CCL3 via the astrocytes in their
vicinity. For instance, it is possible to imagine either that those
neurons express CCR1 or CCR5 receptors (Galasso et al., 1998), or
the response results from CCL3 stimulated astrocytes releasing
some signals to neurons. In fact, astrocytes respond to neuronal
activity or neurotransmitters, through the activation of several
receptors, and can release the gliotransmitters such as ATP, D-ser-
ine, and glutamate, which act on neurons (Halassa and Haydon,
2010).
In this context, it was shown before that either CCL3 or CCL4 do
not depend on the synthesis of new mediators to evoke fever in
rats, which indicates that those chemokines act directly on the
POA area cells (Tavares and Miñano, 2004; Soares et al., 2006). Fur-
thermore, Machado et al. (2007) demonstrated that the injection of
Met-RANTES, a CCR1 and CCR5 receptors antagonist, inhibited LPS-
induced fever indicating that receptors are involved in this re-
sponse. The calcium imaging indicates that CCL3 can activate
POA primary cultured cells. Intra POA injection induces fever re-
sponse in rats. As mentioned before, both astrocytes and neurons
express CCR1 and CCR5 receptors (Bajetto et al., 1999; Galasso
et al., 1998). Anyhow, either the direct stimulation of neurons or
astrocyte-mediated neuronal stimulation can explain the
described PG-independent pyrogenic effect of CCL3 (Soares et al.,2006). Taken together, these results suggest that CCL3 could act di-
rectly on POA cells, via CCR1 or CCR5 to induce fever. Nevertheless
this issue needs further experimental clariﬁcation.
Surprisingly, we did not observe CCL3-induced Ca2+ signaling in
microglial cells. Nonetheless, the participation of microglia on the
CCL3-induced fever cannot be ruled out. The surgery for placing
the guide cannula could induce a microglial activation which
would result in a sensitized pro-inﬂammatory response to a pyro-
genic stimulus. For instance, it was described that the spinal cord
injury induced the expression of CCL1 at the site of injury. On
the other hand no CCR1-immunoreactivity was found in sham con-
trols (Knerlich-Lukoschus et al., 2011). In the light of this informa-
tion we can imagine that the surgery for placing the guide cannula
could have a functional impact on the CCL3 injection. Indeed, this
kind of stab trauma has recently been shown to activate inﬂamma-
tory transcription factors around the injection site of an implanted
cannula (Damm et al. 2013) and thus could have inﬂuenced the
responsiveness of microglial cells in this area. Further studies are
planned to investigate the role of microglia on CCL-3 induced fever
under this experimental condition.
Boddeke et al. (1999) showed that the cells from the POA
responsive to RANTES did not respond to MCP-1 and vice versa.
This implies that the MCP-1 activates CCR2 while RANTES stimu-
lates CCR1 and/or CCR5 in distinct subpopulations of microglia.
Corroborating those data, Tavares and Miñano (2004) had shown
that the microinjection of neutralizing antibody against the CCR5
receptor in the POA does not affect the effects on body temperature
induced by CCL4. However, pre-treatment with the same dose of
anti-CCR5 suppressed the febrile response induced by RANTES
administered to the same location. Thus, the authors demonstrated
that hypothalamic CCR5 is functionally involved in fever induced
by RANTES, but not by CCL4. The latter is suggested to stimulate
the CCR1 receptors. Although these two peptides are structurally
and functionally similar, each of them has distinct characteristics,
which enables them to independently regulate speciﬁc aspects of
the inﬂammatory response of the host.
The overnight incubation with either anti-CCR1 or anti-CCR5
antibody was effective in blocking the Ca++ mobilization in POA
primary cell cultures induced by CCL3. It indicates that, under this
experimental condition, those receptors present a key role on the
CCL3-induced cell activation. Nevertheless, the complete blockade
of the action of CCL3 by each of the applied antibodies is surprising
and makes it quite difﬁcult to discuss the effects of both antibodies
on the stimulation of each receptor separately. Nevertheless, other
authors have found similar effects in different research ﬁelds. For
instance, Oba et al. (2005) have shown that by blocking either
CCR1 or CCR5 the CCL3-induced osteoclast formation and myeloma
cells adhesion to stromal cells are both inhibited. It is worthwhile
to mention that when the authors of this study tried to combine
both antibodies (anti-CCR1 + anti-CCR5) the inhibition was not dif-
ferent from the isolated antibody treatment. Moreover, it is worth-
while to mention that a given antibody not only can have
antagonist-like action, but may also facilitate receptor internaliza-
tion. Therefore the 1-h incubation was probably not sufﬁcient for
this process as reported in some studies showing the effects of
treatment with antibodies against CCR1 and CCR5 on synapto-
somes (Musante et al., 2008; Di Prisco et al., 2012). This observa-
tion suggests that both receptors have a functional role in
mediating CCL3 actions.
In addition to the transient increase of [Ca2+]i, we showed for
the ﬁrst time that CCL3 does not cause an increase of TNF-a or
IL-6 in the POA microculture supernatants. Since fever induced
by TNF-a or IL-6 depends on PGE2 synthesis (Souza et al., 2002;
Rothwell et al., 1991; Hamzic et al., 2013) our present results en-
dorse our previous ﬁnding that CCL3 does not require eicosanoid
synthesis to evoke a febrile response (Soares et al., 2006).
128 D.M. Soares et al. / Brain, Behavior, and Immunity 34 (2013) 120–129In conclusion the present study shows for the ﬁrst time that
CCL-3 injected directly into the rat POA, evoked an integrated feb-
rile response. In parallel this chemokine induces Ca++ signaling in
astrocytes and neurons via both CCR1 and CCR5 receptors when
applied to POA microcultures without stimulating the synthesis
of TNF-a and IL-6. It is a possibility that CCL3-induced fever may
occur via CCR1 and CCR5 receptors stimulation of astrocytes and
neurons from POA.Acknowledgments
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